Related Experiment Video
Updated: Dec 2, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Diabetic ketoacidosis precipitated by Coronavirus disease 2019 infection: Case series
Ibrahim Alsadhan1, Shahad Alruwashid1, Maram Alhamad1
1Endocrinology and Diabetes Division, Department of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Insights
COVID-19 infection can trigger diabetic ketoacidosis (DKA) in patients with or without prior diabetes. Early detection of hyperglycemia is crucial for managing COVID-19 patients with DKA.
Area of Science:
- Endocrinology
- Infectious Diseases
- Critical Care Medicine
Background:
- COVID-19 pandemic significantly impacts global health.
- Hyperglycemia and acute hyperglycemic crises are noted complications of COVID-19.
- No prior reports of DKA in COVID-19 patients in Saudi Arabia.
Purpose of the Study:
- To highlight the significance of hyperglycemia in COVID-19 patient outcomes.
- To report cases of diabetic ketoacidosis in COVID-19 patients in Saudi Arabia.
Main Methods:
- Case series of five patients with DKA and confirmed COVID-19.
- Diagnosis confirmed via real-time reverse transcription-polymerase chain reaction.
- Retrospective review of electronic medical records.
Main Results:
- Five patients presented with DKA and concurrent COVID-19 infection.
- Three patients had pre-existing diabetes; two had new-onset diabetes.
- Four patients recovered; one patient died.
Conclusions:
- COVID-19 infection can precipitate DKA in diabetic and non-diabetic individuals.
- DKA can be the initial presentation of diabetes in COVID-19 patients.
- Close monitoring for hyperglycemia and respiratory status is vital in COVID-19-related DKA management.
Background:
Coronavirus disease 2019 (COVID-19) has evolved into a devastating pandemic since December 2019. Saudi Arabia's first case was reported in March 2020. Subsequently, some 220,000 cases and 2000 deaths were recorded through July 2020. COVID-19 infection aggravates glycemic control and provokes acute hyperglycemic crises, according to some reports. We made the same observations in some of our patients diagnosed with COVID-19. However, we are unaware of any reported cases of diabetic ketoacidosis (DKA) among COVID-19 patients in Saudi Arabia.
Objective:
Highlighting the significance of hyperglycemia on COVID-19 patient outcomes.
Methods:
Five patients with DKA were admitted and diagnosed with COVID-19 based on real-time reverse transcription-polymerase chain reaction assays. Electronic medical records were reviewed and informed consent was obtained before reporting the index cases.
Results:
Five patients presenting with DKA complicating a concurrent COVID-19 infection were reported. Three were known to have preexisting diabetes and 2 had newly diagnosed diabetes based on significantly elevated glycated hemoglobin levels at admission. Four recovered and were discharged to their homes and 1 had a complicated course and died.
Conclusions:
Our cases demonstrate that COVID-19 infection can trigger DKA. DKA can occur among patients who are known to have diabetes mellitus or appears as a first presentation. Clinicians should be extremely careful in checking for admission hyperglycemia and closely monitor respiratory status during fluid resuscitation of COVID-19-related DKA. (Curr Ther Res Clin Exp. 2020; 81:XXX-XXX).
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

